Trump Administration Expands Drug-Pricing Agreements to 26 Manufacturers
President Donald Trump said 26 brand-name and generic drugmakers have now signed most-favored-nation pricing agreements covering lower costs for state Medicaid programs and commitments to U.S. manufacturing.